Two Patients with Extremely Elevated Tumor Markers: Where Is the Malignancy?
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology
![PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1144a56968788915c60eb298e39fcf2d60c86823/5-Table2-1.png "PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar")
PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar
Diagnostic and prognostic value of carcinoembryonic antigen in pancrea | OTT
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol
Cureus | Infection Masquerading as Recurrence of Pancreatic Ductal Adenocarcinoma: A Cautionary Tale | Article
Tumor Markers : All you need to know
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Common benign HPB conditions with associated deranged CA19.9 level | Download Table
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers | PLOS ONE
Tumor Marker Screening For Men & Women At IDC
Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients
Persistent increase of carbohydrate antigen 19‐9 with an unknown reason: A seven‐year follow‐up case - Zhao - Journal of Clinical Laboratory Analysis - Wiley Online Library
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
False-positive rates of CEA according to level (N=597) | Download Scientific Diagram
Non-malignant causes of CA19.9 elevation (medline research) | Download Table
CA19-9 - Wikipedia
Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients
Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas | BMC Cancer | Full Text
Non-malignant causes of CA19.9 elevation (medline research) | Download Table
Should I take a Cancer Marker Test? | Positive Bioscience
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)☆ - ESMO Open
